LOWELL, Mass., Oct. 11, 2016 -- Rapid Micro Biosystems, a leading provider of automated, non-destructive, rapid microbial detection, is pleased to announce the addition of Ed Ognibene as Vice President of Product Development. Ed will report directly to the CEO, Robert Spignesi.
Mr. Ognibene brings over 20 years of technology and product development experience with sophisticated scientific instrumentation. Most recently, he held the position of Director of Engineering / Systems Development at Waters Corporation in the Separation Systems division, where he successfully managed the R&D and Engineering teams from the acquisition of Thar Instruments, Inc., as well as the integration of these groups into the broader corporate development organization. Concurrently, Mr. Ognibene oversaw a major development program to replace a product line with innovative new systems. Prior to this, he was responsible for driving the development of novel industry leading chromatographic platform systems. Before Waters, Mr. Ognibene worked at SatCon Technologies, a MIT start-up, where he managed the Mechanical Engineering Group and was also responsible for Program Management and technology/business development.
“I am thrilled to welcome an executive of Ed’s caliber and experience to our team,” said CEO Robert Spignesi. “His track record of leading innovative technology, product development programs, and organizations will be instrumental to our continued growth and success.”
“I am pleased to step into the VP of Product Development role and take on this assignment during an exciting phase of the company’s growth,” said Mr. Ognibene. “I look forward to ensuring that our customers experience the most innovative products as they implement Rapid Micro Biosystems’ technologies throughout their organizations.”
Ed holds a PhD and MS in Mechanical Engineering from MIT and a BSME from SUNY Stony Brook. Ed is a member of ASME, Tau Beta Pi, and Sigma Xi honor societies.
About Rapid Micro Biosystems
Rapid Micro Biosystems delivers the Growth Direct™ System, an automated, non-destructive rapid detection and enumeration technology based on the compendial method for microbial quality control in pharmaceutical manufacturing. The system automates and accelerates detection and enumeration in the areas of sterility testing, environmental monitoring, and bioburden testing, eliminating manual steps and analysis. The detection technology uses the natural auto-fluorescence of microbes and requires no reagents. For more information about Rapid Micro Biosystems visit www.rapidmicrobio.com
Contact: Eugenia Kendrick Rapid Micro Biosystems [email protected]


SpaceX Seeks FCC Approval for Massive Solar-Powered Satellite Network to Support AI Data Centers
Hyundai Motor Lets Russia Plant Buyback Option Expire Amid Ongoing Ukraine War
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Elon Musk’s SpaceX Acquires xAI in Historic Deal Uniting Space and Artificial Intelligence
Oracle Plans $45–$50 Billion Funding Push in 2026 to Expand Cloud and AI Infrastructure
Boeing Signals Progress on Delayed 777X Program With Planned April First Flight
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Using the Economic Calendar to Reduce Surprise Driven Losses in Forex
Instagram Outage Disrupts Thousands of U.S. Users
Sam Altman Reaffirms OpenAI’s Long-Term Commitment to NVIDIA Amid Chip Report
Qantas to Sell Jetstar Japan Stake as It Refocuses on Core Australian Operations
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns
Jensen Huang Urges Taiwan Suppliers to Boost AI Chip Production Amid Surging Demand
Denso Cuts Profit Forecast Amid U.S. Tariffs and Rising Costs
CK Hutchison Unit Launches Arbitration Against Panama Over Port Concessions Ruling 



